-

VIVAZEN® Applauds Florida’s Emergency Ban on Synthetic 7-OH, Reinforces Commitment to Safe, Natural Kratom

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, a leading botanical wellness brand, today praised the Florida Attorney General’s emergency scheduling of synthetic 7-hydroxymitragynine (7-OH), calling the targeted action a public health win that protects consumers while preserving access to responsibly formulated kratom products.

“We welcome oversight that distinguishes real kratom from harmful counterfeits and synthetics,” said Curtis. “Florida’s action should be a national blueprint.”

Share

Effective August 12, 2025, the emergency rule adds 7-OH at concentrations above 1% by total weight to Schedule I of Florida’s controlled substances list. Crucially, the rule clarifies that “This designation does not apply to mitragynine,” the naturally occurring alkaloid found in kratom leaf. This distinction mirrors recent federal recommendations to classify synthetic 7-OH, not kratom, as a Schedule I substance.

“Florida got this exactly right,” said Steve Curtis, CEO of VIVAZEN®. “Synthetic 7-OH is a chemically manipulated derivative with opioid-like risks. By targeting the synthetic drug without criminalizing the natural plant, Florida is protecting consumers and advancing a model of science-based regulation.”

VIVAZEN® has long advocated for regulatory clarity and quality assurance across the botanical category. All VIVAZEN® products are derived from natural kratom leaf and extract, with no synthetic additives. As part of its quality commitment, VIVAZEN® proactively tests every batch for 7-OH and confirms it is not detected.

“Every product we release undergoes rigorous third-party testing for alkaloid profile, microbial safety, heavy metals, and adulterants,” added Curtis. “That includes routine testing for 7-OH, even though we don’t use it. It’s about trust.”

This announcement comes amid heightened national concern over unregulated synthetic 7-OH. VIVAZEN® supports state-level Kratom Consumer Protection Acts (KCPAs) and is actively involved in real-world evidence (RWE) studies to evaluate kratom’s benefits in daily use.

“We welcome oversight that distinguishes real kratom from harmful counterfeits and synthetics,” said Curtis. “Florida’s action should be a national blueprint.”

To learn more about VIVAZEN®’s science, sourcing, and product safety, visit www.vivazen.com

Contacts

press@vivazen.com

Industry:

VIVAZEN

Release Summary
VIVAZEN® backs Florida’s 7-OH ban; confirms 7-OH is not detected in its products and affirms commitment to strict testing and safety standards.
Release Versions
English

Contacts

press@vivazen.com

Social Media Profiles
Vivazen LinkedIn
More News From VIVAZEN

VIVAZEN® Launches Taboo Tea, a New Non-Alcoholic Social Elixir Made from Natural Botanicals

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, a growing portfolio of botanically crafted beverages and products, today announced the launch of Taboo Tea, an all-new non-alcoholic social elixir crafted with natural botanical kratom and zero apologies. Taboo Tea now is available to consumers in the Tampa, Florida area and will expand to other markets in the near future. Designed for adults seeking alcohol alternatives with more benefits than a traditional soft drink, Taboo Tea is made with naturally derive...

VIVAZEN® Launches Safe Shelves Initiative to Help Protect Consumers and Retailers from Illegal 7-OH and Other Synthetic Drugs

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, the nation’s leading botanical wellness brand, announced the launch of the Safe Shelves Initiative, a new industry-leading effort designed to help consumers and retailers identify legal, high-quality botanical products and distinguish them from the illegal synthetic drugs, including 7-hydroxymitragynine (7-OH) and related compounds, masquerading as natural wellness products. The initiative follows the U.S. Drug Enforcement Administration’s (DEA) decision to c...

VIVAZEN® Commends the Drug Enforcement Administration’s Decision to Schedule Synthetic 7-Hydroxymitragynine (7-OH) and Three Related Drugs

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, the nation’s leading botanical wellness company, welcomes the Drug Enforcement Administration’s (DEA) decision to classify 7-hydroxymitragynine (7-OH) and three related drugs as Schedule I drug. 7-OH is a dangerous synthetic, lab-made drug that HHS and FDA have described as harmful and addictive. 7-OH has raised serious concerns for public health and consumer safety. This move critically distinguishes these harmful synthetic drugs and the natural botanical kr...
Back to Newsroom